Fighting Sanfilippo Syndrome: Charity Match to Fund Vital Research

The fight against Sanfilippo syndrome, a rare neurodegenerative condition often described as a form of childhood Alzheimer’s, takes centre stage this Saturday at Sapiac. Guilhain Higonnet, a father who has navigated the challenges of this genetic disorder for over sixteen years, is organizing the “Match des Phoenix” to raise funds for ongoing research. His commitment stems from a deeply personal journey that began with years of medical uncertainty before a diagnosis was finally reached in 2009.

For the Higonnet family, the road to understanding the condition was marked by seven to eight years of developmental concerns, including language and behavioral issues. After receiving the diagnosis for both his daughter, Laura, and his late son, Elouan, the family had to adapt to a life defined by progressive loss of cognitive and motor functions. Despite the tragic loss of Elouan in 2022, Guilhain and his wife, Francine, continue to provide care for 25-year-old Laura, who communicates primarily through her gaze.

From Isolation to Global Collaboration

In 2011, the couple founded the association Sanfilippo Sud to break the silence surrounding the disease. What began as a desperate appeal on social media quickly evolved into an international network. Families from the United States, Portugal, and Spain connected with the Higonnets, eventually gathering in Saint-Arroumex to share information and collaborate with medical researchers. This collective effort has become a lifeline for those affected by the rare condition, which impacts approximately one in 250,000 children.

Did You Know? The association Sanfilippo Sud was born in 2011 after a social media “bottle in the sea” post by the Higonnet family, which unexpectedly led to a collaborative international network of parents and researchers dedicated to understanding this rare disease.

The Future of Treatment

The persistence of the association and its partners has led to tangible progress in the scientific field. Researchers are currently exploring gene therapy as a potential intervention. If current programmes proceed as expected, a clinical trial for Sanfilippo syndrome type C could be launched within the next two years. Such a development could offer a new future for subsequent generations born with this specific genetic mutation.

Woman finds perfect match in fiancé at annual Phoenix Kidney Walk

Expert Insight: The transition from managing a progressive, incurable condition to potentially participating in clinical trials represents a critical shift in the landscape of rare disease advocacy. By pooling international resources and data, family-led associations like Sanfilippo Sud bridge the gap between patient experience and scientific innovation, significantly accelerating the timeline for potential therapeutic breakthroughs.

Community Support at Sapiac

The upcoming charity event at Sapiac features a series of rugby and football matches, beginning at 14:30. The day concludes with the “Match des Phoenix” at 19:00. All proceeds from the event will be donated to research initiatives aimed at finding a treatment for Sanfilippo syndrome. Tickets are available for €8, with further information accessible via the official online ticketing portal.

Frequently Asked Questions

What is Sanfilippo syndrome?
It is a rare genetic neurodegenerative disease, often compared to childhood Alzheimer’s, which causes a progressive decline in language, motor skills, and cognitive functions.

Is there a cure for this condition?
Currently, there is no established treatment for the disease. However, research is ongoing, and a clinical trial for gene therapy could potentially be launched within two years.

How can the public support the cause?
The public can support the research by attending the “Match des Phoenix” charity event at Sapiac this Saturday, where proceeds from ticket sales and on-site activities will be donated to the cause.

How can community-led initiatives help bridge the gap in medical research for rare, under-funded diseases?